AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Anastassiadou, M Danoun, S Crane, L Baziard-Mouysset, G Payard, M Caignard, DH Rettori, MC Renard, P
Citation: M. Anastassiadou et al., Synthesis and pharmacological evaluation of imidazoline sites I-1 and I-2 selective ligands, BIO MED CH, 9(3), 2001, pp. 585-592

Authors: Comoy, C Guerin, V Pfeiffer, B Rettori, MC Renard, P Guillaumet, G
Citation: C. Comoy et al., Substituted 3-amino and/or 3-aminomethyl-3,4-dihydro-2H-1-benzopyrans: Synthesis and biological activity, BIO MED CH, 8(3), 2000, pp. 483-495

Authors: Barrot, M Rettori, MC Guardiola-Lemaitre, B Jarry, C Le Moal, M Piazza, PV
Citation: M. Barrot et al., Interactions between imidazoline binding sites and dopamine levels in the rat nucleus accumbens, EUR J NEURO, 12(12), 2000, pp. 4547-4551

Authors: Younes, S Labssita, Y Baziard-Mouysset, G Payard, M Rettori, MC Renard, P Pfeiffer, B Caignard, DH
Citation: S. Younes et al., Synthesis and structure-activity relationships of novel arylalkyl 4-benzylpiperazine derivatives as sigma site selective ligands, EUR J MED C, 35(1), 2000, pp. 107-121

Authors: Kopp, C Vogel, E Rettori, MC Delagrange, P Misslin, R
Citation: C. Kopp et al., Reentrainment of the spontaneous locomotor activity rhythm to a daylight reversal in C57BL/6 and C3H/He mice: Implication of melatonin, PHYSL BEHAV, 70(1-2), 2000, pp. 171-176

Authors: Kopp, C Vogel, E Rettori, MC Delagrange, P Misslin, R
Citation: C. Kopp et al., Anxiolytic-like properties of melatonin receptor agonists in mice: Involvement of mt1 and/or MT2 receptors in the regulation of emotional responsiveness, NEUROPHARM, 39(10), 2000, pp. 1865-1871

Authors: Boye, S Pfeiffer, B Renard, P Rettori, MC Guillaumet, G Viaud, MC
Citation: S. Boye et al., N,N-disubstituted aminomethyl benzofuran derivatives: Synthesis and preliminary binding evaluation, BIO MED CH, 7(2), 1999, pp. 335-341

Authors: Kopp, C Vogel, E Rettori, MC Delagrange, P Renard, P Lesieur, D Misslin, R
Citation: C. Kopp et al., Regulation of emotional behaviour by day length in mice: implication of melatonin, BEHAV PHARM, 10(8), 1999, pp. 747-752

Authors: Kopp, C Vogel, E Rettori, MC Delagrange, P Misslin, R
Citation: C. Kopp et al., The effects of melatonin on the behavioural disturbances induced by chronic mild stress in C3H/He mice, BEHAV PHARM, 10(1), 1999, pp. 73-83

Authors: Diouf, O Carato, P Lesieur, I Rettori, MC Caignard, DH
Citation: O. Diouf et al., Synthesis and pharmacological evaluation of novel 4-(4-fluorobenzoyl)piperidine derivatives as mixed 5-HT1A/5-HT2A/D-2 receptor ligands, EUR J MED C, 34(1), 1999, pp. 69-73

Authors: Kopp, C Vogel, E Rettori, MC Delagrange, P Renard, P Lesieur, D Misslin, R
Citation: C. Kopp et al., Antagonistic effects of S 22153, a new mt1 and MT2 receptor ligand, on theneophobia-reducing properties of melatonin in BALB/c mice, PHARM BIO B, 64(1), 1999, pp. 131-136

Authors: Kopp, C Vogel, E Rettori, MC Delagrange, P Guardiola-Lemaitre, B Misslin, R
Citation: C. Kopp et al., Effects of melatonin on neophobic responses in different strains of mice, PHARM BIO B, 63(4), 1999, pp. 521-526

Authors: Weibel, L Rettori, MC Lesieur, D Delagrange, P Renard, P Van Reeth, O
Citation: L. Weibel et al., A single oral dose of S 22153, a melatonin antagonist, blocks the phase advancing effects of melatonin in C3H mice, BRAIN RES, 829(1-2), 1999, pp. 160-166
Risultati: 1-13 |